- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HighTide Therapeutics Inc (2511)
HighTide Therapeutics Inc stock price live, this page displays HK 2511 stock exchange data. View the 2511 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the HighTide Therapeutics Inc real time stock price chart below.
What Is the HighTide Therapeutics Inc Stock Price Today?
The HighTide Therapeutics Inc stock price today is 3.25.
What Is the Stock Symbol for HighTide Therapeutics Inc?
The stock symbol for HighTide Therapeutics Inc is ""2511.""
What Stock Exchange Does HighTide Therapeutics Inc Trade On?
HighTide Therapeutics Inc is listed and trades on the Hong Kong stock exchange.
Is HighTide Therapeutics Inc a Good Stock to Buy?
Determining whether HighTide Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2511 quote. (ISIN: KYG4568L1023)
What Is the HighTide Therapeutics Inc Stock Price Today?
The HighTide Therapeutics Inc stock price today is 3.25.
What Is the Stock Symbol for HighTide Therapeutics Inc?
The stock symbol for HighTide Therapeutics Inc is ""2511.""
What Stock Exchange Does HighTide Therapeutics Inc Trade On?
HighTide Therapeutics Inc is listed and trades on the Hong Kong stock exchange.
Is HighTide Therapeutics Inc a Good Stock to Buy?
Determining whether HighTide Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2511 quote. (ISIN: KYG4568L1023)
Hong Kong
Currency in HKD
3.25
-0.08(-2.40%)
Closed·
Fair Value
An estimate of a HighTide Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.20
3.35
52 wk Range
0.72
3.92
2511 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2511 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a HighTide Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.203.35
52 wk Range
0.723.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2511 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a HighTide Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
HighTide Therapeutics Inc Company Profile
HighTide Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China. Its lead drug candidate is HTD1801, which is in phase III clinical trial to treat type 2 diabetes mellitus (T2DM); in phase IIb clinical trial to treat metabolic dysfunction-associated steatohepatitis (MASH); in phase II clinical trial to treat severe hypertriglyceridemia; and in phase II clinical trial to treat primary sclerosing cholangitis, as well as in phase II clinical trial to treat primary biliary cholangitis. The company is also developing HTD4010, a polypeptide drug, which is in phase I clinical trial for the treatment of alcoholic hepatitis; HTD1804 that is in preclinical trial to treat obesity; HTD1805, a multifunctional small molecule drug, which is in preclinical trial for the treatment of metabolic diseases; HTF1057 a preclinical-stage a drug candidate for the treatment of neurodegenerative diseases; HTF1037 a preclinical-stage for the treatment of obesity and comorbidities; and HTD2802 that is in preclinical trial for treating inflammatory bowel disease. HighTide Therapeutics, Inc. was founded in 2011 and is headquartered in Shenzhen, China.
Compare 2511 to Peers and Sector
Metrics to compare | 2511 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2511PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.6x | −53.0x | −0.5x | |
PEG Ratio | −0.06 | 0.05 | 0.00 | |
Price/Book | 4.1x | 6.5x | 2.6x | |
Price / LTM Sales | - | 23.6x | 3.3x | |
Upside (Analyst Target) | - | −10.0% | 42.8% | |
Fair Value Upside | Unlock | −15.2% | 6.5% | Unlock |
Earnings
Latest Release
Apr 23, 2025
EPS / Forecast
-0.38 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does HighTide Therapeutics Trade On?
HighTide Therapeutics is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for HighTide Therapeutics?
The stock symbol for HighTide Therapeutics is "2511."
What Is the HighTide Therapeutics Market Cap?
As of today, HighTide Therapeutics market cap is 1.86B.
What Is HighTide Therapeutics's Earnings Per Share (TTM)?
The HighTide Therapeutics EPS (TTM) is -0.84.
From a Technical Analysis Perspective, Is 2511 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has HighTide Therapeutics Stock Split?
HighTide Therapeutics has split 0 times.
How Many Employees Does HighTide Therapeutics Have?
HighTide Therapeutics has 70 employees.
What is the current trading status of HighTide Therapeutics (2511)?
As of 06 Aug 2025, HighTide Therapeutics (2511) is trading at a price of 3.25, with a previous close of 3.25. The stock has fluctuated within a day range of 3.20 to 3.35, while its 52-week range spans from 0.72 to 3.92.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.